| Genomic Valley Biotech Ltd | Industry : (Miscellaneous) | |
|---|---|---|
|
BSE Code : 539206 |
NSE Symbol : - |
P/E(TTM) : 99.04 |
|
ISIN Demat : INE574D01010 |
Div & Yield% : - |
EPS(TTM) : 0.83 |
|
Book Value(₹) : 12.50 |
Market Cap(₹Cr) : 25.11 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.21 | 0.16 | 0.00 | 0.04 | 0.07 | 0.06 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.21 | 0.16 | 0.00 | 0.04 | 0.07 | 0.06 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.21 | 0.16 | 0.00 | 0.04 | 0.07 | 0.06 |
| Total Expenditure | 0.06 | 0.03 | 0.04 | 0.02 | 0.04 | 0.03 |
| PBIDT | 0.15 | 0.13 | -0.04 | 0.02 | 0.02 | 0.03 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.15 | 0.13 | -0.04 | 0.02 | 0.02 | 0.03 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.15 | 0.13 | -0.04 | 0.02 | 0.02 | 0.03 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.15 | 0.13 | -0.04 | 0.02 | 0.02 | 0.03 |
| EPS (Unit Curr.) | 0.48 | 0.42 | -0.15 | 0.07 | 0.08 | 0.09 |
| EPS (Adj) (Unit Curr.) | 0.48 | 0.42 | -0.15 | 0.07 | 0.08 | 0.09 |
| Calculated EPS (Unit Curr.) | 0.48 | 0.42 | -0.15 | 0.07 | 0.08 | 0.09 |
| Calculated EPS (Adj) (Unit Curr.) | 0.48 | 0.42 | -0.15 | 0.07 | 0.08 | 0.09 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.93 | 1.67 | -0.58 | 0.28 | 0.30 | 0.35 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.93 | 1.67 | -0.58 | 0.28 | 0.30 | 0.35 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 71.43 | 81.25 | 0.00 | 50.00 | 28.57 | 50.00 |
| PBDTM(%) | 71.43 | 81.25 | 0.00 | 50.00 | 28.57 | 50.00 |
| PATM(%) | 71.43 | 81.25 | 0.00 | 50.00 | 28.57 | 50.00 |